A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

• 

• 
  • The Journal
  • Editor-In-Chief
  • Editorial Calendar
  • Submissions
  • Advertising
  • Permissions & Reprints
  • Privacy Policy

• 
  • Subscribe
  • Renew
  • Prices
  • Free Sample

• 
  • View Shopping Cart
  • Back Issues
  • Articles
  • Library Archives
  • Compounding Theme Archives
  • Other Products

• 
  • Supplemental Content and Errata
  • Training and Education
  • IJPC-PCAB SOP Matrix
  • USP GAP Analysis
  • Compounders' Network List
  • Patient Information
  • Videos
  • Compounders' Resource Directory

• 

• 

Standard Operating Procedure: Determining and Documenting the Commercial Unavailability of a Manufactured Drug Product

Author(s):  Allen Loyd V Jr

Issue:  Jul/Aug 2004 - Wound Care
View All Articles in Issue

Abstract:  The purpose of this procedure is to provide a method for documenting the commercial unavailability of a manufactured drug product. A Documentation of the Unavailability of a Commercial Manufactured Drug Product Form, suitable for photocopying and using in the pharmacy, is also provided.

Related Keywords: SOP, for determining and documenting the commercial unavailability of a manufactured drug, Standard operating procedure, for determining and documenting the commercial unavailability of a manufactured drug

Related Categories: SOPs, DISCONTINUED FORMULATIONS

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details)	Author	Issue	Page	View/Buy
Standard Operating Procedure: Determining and Documenting the Commercial Unavailability of a Manufactured Drug Product	Allen Loyd V Jr	Jul/Aug 2004	292-293	Buy
Determining the Availability of a Commercial Drug		Jan/Feb 2003	44-45	Buy
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances	Miller David G	Jul/Aug 2015	303-305	Buy
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA	Cabaleiro Joe	Sep/Oct 2021	358-362	Buy
PreScription: Compounded Drugs Often Become Manufactured Drugs	Allen Loyd V Jr	Nov/Dec 2022	444	Buy
Standard Operating Procedure: SOP Master Book--Maintenance	Allen Loyd V Jr	Mar/Apr 2005	145	Buy
Standard Operating Procedure: Incubator Temperature Monitoring	Allen Loyd V Jr	May/Jun 2003	228-229	Buy
Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion	Desai Narendra R, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A	Sep/Oct 2007	426-432	Buy
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective	Timko Robert J, Crooker Philip EM	Mar/Apr 2014	101-111	Buy
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists	Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake	Sep/Oct 2015	377-380	Buy